August 21, 2025 Tianjin, China - Jecho Biopharmaceuticals Co., Ltd. (hereinafter referred to as “Jechobio”), a global, clinical stage biopharmaceutical company advancing medicines focusing in oncology, today announced that the…
June 25, 2025 Inside Precision Medicine highlights GPC3-targeting imaging agent to improve liver cancer detection A recent article highlights the clinical results from a GPC3-targeting agent, 68Ga-a-GPC3-scF, which was shown…
21 April, 2025 – Jecho Biopharmaceuticals Co., Ltd. (hereinafter referred to as "Jechobio"), in collaboration with Wuhan Raydif Biotechnology Co., Ltd. (hereinafter referred to as "Raydif"), and Grand Pharmaceutical Group…